Back to Results
First PageMeta Content



FDA Grants Fast Track Designation to Visterra’s VIS410 for Treatment of Hospitalized Patients with Influenza A - Company Plans to Initiate Phase 2b Clinical Trial in Early 2018 Cambridge, MA – November 1, 2017 – Vi
Add to Reading List

Document Date: 2017-11-01 01:14:19


Open Document

File Size: 111,89 KB

Share Result on Facebook
UPDATE